【摘要】 目的：评估冠脉血运重建术后应用复方丹参滴丸治疗的安全性与有效性。方法：选择2016年7月-2018年7月笔者所在医院收治的50例原发性冠脉疾病患者作为研究对象，应用随机对照研究按照1∶1的比例将其随机分为对照组和联合组，每组25例。比较两组术后12个月内靶病变失败率及全血黏度高切、血小板黏附率、红细胞聚集指数。结果：联合组患者术后12个月内靶病变失败率为4.00%，显著低于对照组的40.00%，差异有统计学意义(P<0.05)。联合组患者治疗后全血黏度高切、血小板黏附率、红细胞聚集指数均显著低于对照组，差异有统计学意义(P<0.05)。结论：冠脉血运重建术后应用复方丹参滴丸治疗，可显著降低患者术后12个月内靶病变失败率和血液流变学相关指标，值得推广。

    【关键词】 复方丹参滴丸 冠脉血运重建 安全性

    [Abstract] Objective： To evaluate the safety and effectiveness of Compound Danshen Dropping Pills after coronary revascularization. Method： Fifty patients with primary coronary artery disease admitted in our hospital from July 2016 to July 2018 were selected as the study subjects. They were randomly divided into the control group and the combined group according to the ratio of 1∶1 in a randomized controlled study ......